Ligand · MO9

MO9 · (1R)-2-[(cyanomethyl)amino]-1-({[2-(difluoromethoxy)benzyl]sulfonyl}methyl)-2-oxoethyl morpholine-4-carboxylate

MO9, (1R)-2-[(cyanomethyl)amino]-1-({[2-(difluoromethoxy)benzyl]sulfonyl}methyl)-2-oxoethyl morpholine-4-carboxylate (C18 H21 F2 N3 O7 S, 461.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…

Component: MO9
Formula: C18 H21 F2 N3 O7 S
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

MO9 in 2 structures; the first of them:

2G7Y · Human Cathepsin S with inhibitor CRA-16981 · MO9 A999 · binds GLY23, CYS25, TRP26, GLY59, LYS61, CYS63, ASN64, GLY65 and 10 more
2G7Y · Human cathepsin S with inhibitor cra-16981 · MO9 A999 · binds GLY23, CYS25, TRP26, GLY59, LYS61, CYS63, ASN64, GLY65 and 10 more

Residues it binds most

GLY 4, PHE 4, ASN 4, CYS 4, HIS 4, LYS 4, MET 4, TRP 4, VAL 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.